Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VIRGILIO GERALD H EVIDENTE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1730163353
CMS profile
351522
Location
SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$71,586.38

216 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VIRGILIO GERALD H EVIDENTE

NPI 1730163353 · CMS profile ID 351522

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1730163353?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VIRGILIO GERALD H EVIDENTE, NPI 1730163353, CMS profile ID 351522. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1730163353?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). VIRGILIO GERALD H EVIDENTE, NPI 1730163353, CMS profile ID 351522. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1730163353?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
VIRGILIO GERALD H EVIDENTE, NPI 1730163353, CMS profile ID 351522, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1730163353?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

216 matching records · $71,586.38 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 216 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 216.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merz Pharmaceuticals, LLC $3.8309/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232569168 CMS
Boston Scientific Corporation $21.5809/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181371748 CMS
Ipsen Biopharmaceuticals, Inc $25.8909/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208838481 CMS
Medtronic, Inc. $26.3709/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219020953 CMS
ABBVIE INC. $25.0009/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201829863 CMS
Ipsen Biopharmaceuticals, Inc $31.7909/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208838479 CMS
ABBVIE INC. $24.3009/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201829861 CMS
MDD US Operations, LLC $20.5109/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241857170 CMS
Medtronic, Inc. $6.6909/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219020951 CMS
ABBVIE INC. $1,600.0009/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1201829859 CMS
MDD US Operations, LLC $45.4509/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857162 CMS
MDD US Operations, LLC $129.5909/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857172 CMS
MDD US Operations, LLC $49.5709/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857174 CMS
MDD US Operations, LLC $397.9909/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241857168 CMS
Teva Pharmaceuticals USA, Inc. $1,666.0009/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1247269321 CMS
ABBVIE INC. $17.9609/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201829857 CMS
Teva Pharmaceuticals USA, Inc. $433.2909/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1247269317 CMS
Teva Pharmaceuticals USA, Inc. $4,165.0009/09/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1247269319 CMS
Teva Pharmaceuticals USA, Inc. $12.6909/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247269333 CMS
Amneal Pharmaceuticals LLC $19.2709/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1220532965 CMS
ACADIA Pharmaceuticals Inc $19.9509/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247772302 CMS
Lilly USA, LLC $24.1508/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186982036 CMS
ACADIA Pharmaceuticals Inc $22.3208/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247772300 CMS
MDD US Operations, LLC $7.9608/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857108 CMS
MDD US Operations, LLC $5.0808/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857110 CMS
MDD US Operations, LLC $19.8808/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857112 CMS
Teva Pharmaceuticals USA, Inc. $435.4408/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1247269311 CMS
Teva Pharmaceuticals USA, Inc. $4,165.0008/26/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1247269313 CMS
Eisai Inc. $10.7608/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244518355 CMS
Teva Pharmaceuticals USA, Inc. $750.0008/25/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1247269357 CMS
Teva Pharmaceuticals USA, Inc. $34.7208/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247269331 CMS
MDD US Operations, LLC $407.9608/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241857166 CMS
Teva Pharmaceuticals USA, Inc. $16.1208/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247269305 CMS
Teva Pharmaceuticals USA, Inc. $616.8808/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1247269307 CMS
Teva Pharmaceuticals USA, Inc. $4,165.0008/21/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1247269309 CMS
MDD US Operations, LLC $19.9108/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857106 CMS
Medtronic, Inc. $20.6708/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219020949 CMS
Boston Scientific Corporation $27.7508/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181371746 CMS
MDD US Operations, LLC $12.0308/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857102 CMS
MDD US Operations, LLC $10.2208/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857104 CMS
PFIZER INC. $17.7908/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231670044 CMS
Abbott Laboratories $22.2508/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240723035 CMS
Ipsen Biopharmaceuticals, Inc $32.0908/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208838477 CMS
ABBVIE INC. $34.8408/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201829855 CMS
Lilly USA, LLC $22.9208/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186982034 CMS
Neurocrine BioSciences, Inc. $20.4007/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243024354 CMS
Supernus Pharmaceuticals, Inc. $20.5107/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244905312 CMS
Teva Pharmaceuticals USA, Inc. $44.3107/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247269303 CMS
MDD US Operations, LLC $9.0307/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857120 CMS
MDD US Operations, LLC $8.6107/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241857122 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $22,672.59 156
PY2020 $39,625.79 150
PY2021 $14,591.56 155
PY2022 $28,742.40 168
PY2023 $19,890.20 191
PY2024 $34,145.15 188
PY2025 $71,586.38 216

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $20,910.44 12
PY2024 Principal investigator $83,695.74 55
PY2023 Recipient $1,500.00 1
PY2023 Principal investigator $24,317.35 5
PY2022 Principal investigator $92,695.58 20
PY2021 Principal investigator $147,172.66 23
PY2020 Recipient $8,000.00 1
PY2020 Principal investigator $37,856.00 10
PY2019 Recipient $12,000.00 2
PY2019 Principal investigator $75,749.61 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ipsen Pharma SAS $2,000.00 12/30/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304185
Principal investigator 1 Ipsen Pharma SAS $1,250.00 12/30/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304187
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304171
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304173
Principal investigator 1 Ipsen Pharma SAS $1,832.97 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304175
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304177
Principal investigator 1 Ipsen Pharma SAS $1,987.38 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304179
Principal investigator 1 Ipsen Pharma SAS $1,832.97 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304181
Principal investigator 1 Ipsen Pharma SAS $1,832.97 08/08/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304183
Principal investigator 1 Ipsen Pharma SAS $1,906.13 04/01/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304169
Principal investigator 1 Ipsen Pharma SAS $1,101.75 02/17/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304167
Principal investigator 1 Ipsen Pharma SAS $1,204.13 01/29/2025 Non-covered Recipient Entity
Movement Disorders Center Of Arizona, Llc
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison With OnabotulinumtoxinA (Botox) When Treating Adults With Upper Limb Spasticity No dispute reported 06/30/2026 1184304165